Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics

Michael J. Greenberg, James D. Watt, Michelle Jones, Katarzyna Kazmierczak, Danuta Szczesna-Cordary, Jeffrey R. Moore

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The myosin regulatory light chain (RLC) wraps around the alpha-helical neck region of myosin. This neck region has been proposed to act as a lever arm, amplifying small conformational changes in the myosin head to generate motion. The RLC serves an important structural role, supporting the myosin neck region and a modulatory role, tuning the kinetics of the actin myosin interaction. Given the importance of the RLC, it is not surprising that mutations of the RLC can lead to familial hypertrophic cardiomyopathy (FHC), the leading cause of sudden cardiac death in people under 30. Population studies identified two FHC mutations located near the cationic binding site of the RLC, R58Q and N47K. Although these mutations are close in sequence, they differ in clinical presentation and prognosis, with R58Q showing a more severe phenotype. We examined the molecular based changes in myosin that are responsible for the disease phenotype by purifying myosin from transgenic mouse hearts expressing mutant myosins and examining actin filament sliding using the in vitro motility assay. We found that both R58Q and N47K show reductions in force compared to the wild type that could result in compensatory hypertrophy. Furthermore, we observed a higher ATPase rate and an increased activation at submaximal calcium levels for the R58Q myosin that could lead to decreased efficiency and incomplete cardiac relaxation, potentially explaining the more severe phenotype for the R58Q mutation.

Original languageEnglish
Pages (from-to)108-115
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Myosins
Mechanics
Cardiomyopathies
Light
Mutation
Familial Hypertrophic Cardiomyopathy
Neck
Phenotype
Myosin Light Chains
Sudden Cardiac Death
Actin Cytoskeleton
Hypertrophy
Transgenic Mice
Adenosine Triphosphatases
Actins
Binding Sites
Calcium
Population

Keywords

  • ATPase
  • Calcium binding site
  • FHC
  • Motility assay
  • Optical trapping
  • RLC

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics. / Greenberg, Michael J.; Watt, James D.; Jones, Michelle; Kazmierczak, Katarzyna; Szczesna-Cordary, Danuta; Moore, Jeffrey R.

In: Journal of Molecular and Cellular Cardiology, Vol. 46, No. 1, 01.01.2009, p. 108-115.

Research output: Contribution to journalArticle

Greenberg, Michael J. ; Watt, James D. ; Jones, Michelle ; Kazmierczak, Katarzyna ; Szczesna-Cordary, Danuta ; Moore, Jeffrey R. / Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics. In: Journal of Molecular and Cellular Cardiology. 2009 ; Vol. 46, No. 1. pp. 108-115.
@article{071b83b4d9bf44879a92240c1f2d3f1a,
title = "Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics",
abstract = "The myosin regulatory light chain (RLC) wraps around the alpha-helical neck region of myosin. This neck region has been proposed to act as a lever arm, amplifying small conformational changes in the myosin head to generate motion. The RLC serves an important structural role, supporting the myosin neck region and a modulatory role, tuning the kinetics of the actin myosin interaction. Given the importance of the RLC, it is not surprising that mutations of the RLC can lead to familial hypertrophic cardiomyopathy (FHC), the leading cause of sudden cardiac death in people under 30. Population studies identified two FHC mutations located near the cationic binding site of the RLC, R58Q and N47K. Although these mutations are close in sequence, they differ in clinical presentation and prognosis, with R58Q showing a more severe phenotype. We examined the molecular based changes in myosin that are responsible for the disease phenotype by purifying myosin from transgenic mouse hearts expressing mutant myosins and examining actin filament sliding using the in vitro motility assay. We found that both R58Q and N47K show reductions in force compared to the wild type that could result in compensatory hypertrophy. Furthermore, we observed a higher ATPase rate and an increased activation at submaximal calcium levels for the R58Q myosin that could lead to decreased efficiency and incomplete cardiac relaxation, potentially explaining the more severe phenotype for the R58Q mutation.",
keywords = "ATPase, Calcium binding site, FHC, Motility assay, Optical trapping, RLC",
author = "Greenberg, {Michael J.} and Watt, {James D.} and Michelle Jones and Katarzyna Kazmierczak and Danuta Szczesna-Cordary and Moore, {Jeffrey R.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.yjmcc.2008.09.126",
language = "English",
volume = "46",
pages = "108--115",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics

AU - Greenberg, Michael J.

AU - Watt, James D.

AU - Jones, Michelle

AU - Kazmierczak, Katarzyna

AU - Szczesna-Cordary, Danuta

AU - Moore, Jeffrey R.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - The myosin regulatory light chain (RLC) wraps around the alpha-helical neck region of myosin. This neck region has been proposed to act as a lever arm, amplifying small conformational changes in the myosin head to generate motion. The RLC serves an important structural role, supporting the myosin neck region and a modulatory role, tuning the kinetics of the actin myosin interaction. Given the importance of the RLC, it is not surprising that mutations of the RLC can lead to familial hypertrophic cardiomyopathy (FHC), the leading cause of sudden cardiac death in people under 30. Population studies identified two FHC mutations located near the cationic binding site of the RLC, R58Q and N47K. Although these mutations are close in sequence, they differ in clinical presentation and prognosis, with R58Q showing a more severe phenotype. We examined the molecular based changes in myosin that are responsible for the disease phenotype by purifying myosin from transgenic mouse hearts expressing mutant myosins and examining actin filament sliding using the in vitro motility assay. We found that both R58Q and N47K show reductions in force compared to the wild type that could result in compensatory hypertrophy. Furthermore, we observed a higher ATPase rate and an increased activation at submaximal calcium levels for the R58Q myosin that could lead to decreased efficiency and incomplete cardiac relaxation, potentially explaining the more severe phenotype for the R58Q mutation.

AB - The myosin regulatory light chain (RLC) wraps around the alpha-helical neck region of myosin. This neck region has been proposed to act as a lever arm, amplifying small conformational changes in the myosin head to generate motion. The RLC serves an important structural role, supporting the myosin neck region and a modulatory role, tuning the kinetics of the actin myosin interaction. Given the importance of the RLC, it is not surprising that mutations of the RLC can lead to familial hypertrophic cardiomyopathy (FHC), the leading cause of sudden cardiac death in people under 30. Population studies identified two FHC mutations located near the cationic binding site of the RLC, R58Q and N47K. Although these mutations are close in sequence, they differ in clinical presentation and prognosis, with R58Q showing a more severe phenotype. We examined the molecular based changes in myosin that are responsible for the disease phenotype by purifying myosin from transgenic mouse hearts expressing mutant myosins and examining actin filament sliding using the in vitro motility assay. We found that both R58Q and N47K show reductions in force compared to the wild type that could result in compensatory hypertrophy. Furthermore, we observed a higher ATPase rate and an increased activation at submaximal calcium levels for the R58Q myosin that could lead to decreased efficiency and incomplete cardiac relaxation, potentially explaining the more severe phenotype for the R58Q mutation.

KW - ATPase

KW - Calcium binding site

KW - FHC

KW - Motility assay

KW - Optical trapping

KW - RLC

UR - http://www.scopus.com/inward/record.url?scp=57149087461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149087461&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2008.09.126

DO - 10.1016/j.yjmcc.2008.09.126

M3 - Article

C2 - 18929571

AN - SCOPUS:57149087461

VL - 46

SP - 108

EP - 115

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -